Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccination

AM Valk, JBD Keijser, KPJ van Dam, T2B Immunity Against SARS-CoV-2, EW Stalman, L Wieske, M Steenhuis, LYL Kummer, PI Spuls, MW Bekkenk, AH Musters, NF Post, AL Bosma, B Horváth, DJ Hijnen, CRG Schreurs, ZLE van Kempen, J Killestein, AG Volkers, SW TasL Boekel, GJ Wolbink, S Keijzer, NIL Derksen, M van Deelen, G van Mierlo, TW Kuijpers, F Eftimov, SM van Ham, A ten Brinke, T Rispens*

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

8 Citations (Web of Science)
44 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccination'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology